Review Article
Author Details :
Volume : 8, Issue : 2, Year : 2022
Article Page : 95-108
https://doi.org/10.18231/j.ijooo.2022.022
Abstract
Pterygium is an ocular surface disorder associated with fibrovascular growth and elastotic degeneration of the collagen in conjunctiva and cornea. It has high incidence in tropical countries like India especially in males because of abundance of UV light exposure. It does not hamper vision until in later stages when visual axis is involved. But the burden of disease has increased due to recurrence rates post surgery which is considered to be mainstay of pterygium treatments. Recently there have been advances regarding understanding of pathophysiology and management of pterygium. This article aims to review the recent developments in pathophysiology including genetics, various treatment modalities available beside surgery e.g. adjunctive therapies and management of recurrence pterygium.
Keywords: Pterygium, Recurrence, Adjuvant therapy, Pathophysiology, Conjunctival auto graft, Mitomycin C
How to cite : Gupta A, Maurya R P, Manisha, Kadir S M U, Patel A, Devi A, Patel E, Singh S, Recent update on pterygium. IP Int J Ocul Oncol Oculoplasty 2022;8(2):95-108
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 25-06-2022
Accepted : 15-06-2022
Viewed: 7412
PDF Downloaded: 2824